{"id":"pregabalin-dose-level-2","safety":{"commonSideEffects":[{"rate":"20–30%","effect":"Dizziness"},{"rate":"15–25%","effect":"Somnolence"},{"rate":"5–10%","effect":"Dry mouth"},{"rate":"5–10%","effect":"Edema (peripheral)"},{"rate":"5–10%","effect":"Weight gain"},{"rate":"5–10%","effect":"Blurred vision"},{"rate":"5–10%","effect":"Ataxia"}]},"_chembl":{"chemblId":"CHEMBL1059","moleculeType":"Small molecule","molecularWeight":"159.23"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"By binding to presynaptic calcium channels, pregabalin decreases calcium influx and subsequently reduces the release of glutamate, norepinephrine, and substance P. This modulation of neurotransmitter release underlies its analgesic, anxiolytic, and anticonvulsant effects. The drug is used across multiple neurological and pain conditions where excessive neuronal excitability contributes to pathology.","oneSentence":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:02.046Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury)"},{"name":"Partial-onset seizures (adjunctive therapy)"},{"name":"Generalized anxiety disorder"},{"name":"Fibromyalgia"}]},"trialDetails":[{"nctId":"NCT06619860","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2024-10-18","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":300},{"nctId":"NCT07456761","phase":"NA","title":"Effect of Low-dose Pregabalin Retard (82.5 mg) Versus Standard-dose Pregabalin Retard (165 mg) on Postoperative Pain and Opioid Consumption After Elective Laparoscopic Abdominal Surgery: a Randomized, Double-blind, Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"South Egypt Cancer Institute","startDate":"2026-04","conditions":"Laparoscopic Abdominal Surgeries","enrollment":80},{"nctId":"NCT07157852","phase":"NA","title":"The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-05","conditions":"Fibromyalgia, Pregabalin, Mirogabalin","enrollment":674},{"nctId":"NCT07196657","phase":"NA","title":"The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-30","conditions":"Fibromyalgia, Pregabalin, Pain","enrollment":1116},{"nctId":"NCT07382921","phase":"NA","title":"Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01-30","conditions":"Fibromyalgia, Pregabalin, Pain","enrollment":164},{"nctId":"NCT07230197","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Dexmedetomidine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-30","conditions":"Fibromyalgia, Pregabalin, Dexmedetomidine","enrollment":400},{"nctId":"NCT07171320","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Desvenlafaxine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-15","conditions":"Fibromyalgia, Pregabalin, Pain","enrollment":384},{"nctId":"NCT07208357","phase":"NA","title":"The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-10-20","conditions":"Fibromyalgia, Pregabalin, Duloxetine","enrollment":384},{"nctId":"NCT07084753","phase":"NA","title":"Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"IVO JURISIC","startDate":"2025-07-30","conditions":"Obese Patients, Bariatric Surgical Pain, Bariatric Surgery (Sleeve Gastrectomy )","enrollment":36},{"nctId":"NCT06990854","phase":"NA","title":"Electroacupuncture for PHN: Efficacy and Biomarker Evaluation in a Multicenter, Randomized, Sham-Controlled Trial Protocol","status":"NOT_YET_RECRUITING","sponsor":"Dexiong Han","startDate":"2025-07-01","conditions":"Postherpetic Neuralgia ( PHN )","enrollment":207},{"nctId":"NCT05660538","phase":"PHASE2","title":"Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2022-12-20","conditions":"Diabetic Peripheral Neuropathy","enrollment":194},{"nctId":"NCT07013773","phase":"PHASE1","title":"To Evaluate the Effect of Food on the Pharmacokinetics of Y-4 Tablets in Healthy Subjects","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-05-19","conditions":"Healthy Male and Female Subjects","enrollment":20},{"nctId":"NCT06935721","phase":"PHASE1","title":"Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-03-28","conditions":"Healthy Male and Female Subjects","enrollment":10},{"nctId":"NCT06914180","phase":"NA","title":"Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic; Neuralgia, Trigeminal (Etiology)","enrollment":174},{"nctId":"NCT06516094","phase":"PHASE3","title":"Efficacy and Safety in the Combination of Celecoxib / Pregabalin / Vitamin B for Low Back Chronic Pain","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2024-04-11","conditions":"Chronic Low-back Pain","enrollment":192},{"nctId":"NCT06261801","phase":"NA","title":"Efficacy of Electroacupuncture Combined With Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: a Multicenter Randomized Controlled Trial Study Protocol","status":"RECRUITING","sponsor":"The Third People's Hospital of Hangzhou","startDate":"2024-02-07","conditions":"Trigeminal Herpetic Neuralgia","enrollment":102},{"nctId":"NCT03928093","phase":"PHASE3","title":"Pregabalin Treatment for RDEB Pain and Itch","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2019-08-07","conditions":"Pain, Neuropathic, Itch, Epidermolysis Bullosa","enrollment":1},{"nctId":"NCT05640479","phase":"PHASE4","title":"Pregabalin Versus Dexmedetomidine for Delirium Prevention After Cardiac Surgery","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-12-15","conditions":"Pregabalin, Dexmedetomidine, Delirium","enrollment":60},{"nctId":"NCT01480765","phase":"PHASE4","title":"Preventing Pain After Heart Surgery","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2011-12-12","conditions":"Pain, Hyperalgesia, Chronic Illness","enrollment":150},{"nctId":"NCT06488586","phase":"","title":"IV Ketamine Vs. in Esketamine for MDD TRD","status":"RECRUITING","sponsor":"Gustavo Vazquez","startDate":"2023-03-20","conditions":"Treatment Resistant Depression","enrollment":80},{"nctId":"NCT06490484","phase":"PHASE2","title":"Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin","status":"RECRUITING","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2024-04-19","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":90},{"nctId":"NCT03325959","phase":"NA","title":"Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2017-03-01","conditions":"Fibromyalgia, Hyperbaric Oxygen","enrollment":76},{"nctId":"NCT04316702","phase":"NA","title":"Hyperbaric Oxygen Therapy Compared to Pharmaceutical in Fibromyalgia With Emotional Trauma","status":"COMPLETED","sponsor":"Assaf-Harofeh Medical Center","startDate":"2020-03-01","conditions":"Fibromyalgia, Emotional Trauma","enrollment":48},{"nctId":"NCT06077786","phase":"PHASE1","title":"A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants","status":"COMPLETED","sponsor":"H. Lundbeck A/S","startDate":"2023-10-13","conditions":"Healthy Participants","enrollment":26},{"nctId":"NCT04478526","phase":"NA","title":"Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions","status":"COMPLETED","sponsor":"Dr. Nazanin Alavi","startDate":"2020-04-29","conditions":"Generalized Anxiety Disorder","enrollment":115},{"nctId":"NCT04990804","phase":"PHASE4","title":"Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2021-08-01","conditions":"Opioid Use, Spinal Diseases, Surgery--Complications","enrollment":8},{"nctId":"NCT05763550","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia","status":"COMPLETED","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2023-02-27","conditions":"Herpetic Neuralgia","enrollment":331},{"nctId":"NCT04648540","phase":"EARLY_PHASE1","title":"Multimodal Opioid-free Anesthesia Versus Opioid-based Anesthesia for Patients Undergoing Cardiac Valve Surgeries: RCT","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-12-01","conditions":"Anesthesia","enrollment":60},{"nctId":"NCT03794388","phase":"PHASE3","title":"Evaluation in the Treatment of Neuropathic Pain Post Breast Surgery","status":"COMPLETED","sponsor":"Institut Cancerologie de l'Ouest","startDate":"2019-03-19","conditions":"Breast Cancer Patient","enrollment":140},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT05704374","phase":"NA","title":"The Effect of Sympathetic Dysfunction on Muscle Spindle in Fibromyalgia","status":"UNKNOWN","sponsor":"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","startDate":"2023-11-02","conditions":"Fibromyalgia","enrollment":36},{"nctId":"NCT05829148","phase":"EARLY_PHASE1","title":"The Effect of Dexmedetomidine, Melatonin and Pregabalin","status":"UNKNOWN","sponsor":"Egymedicalpedia","startDate":"2023-05-01","conditions":"Endoscopic Sinus Surgery","enrollment":120},{"nctId":"NCT04641273","phase":"PHASE2","title":"A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain","status":"TERMINATED","sponsor":"Bayer","startDate":"2021-01-22","conditions":"Neuropathic Pain Associated With Diabetic Peripheral Neuropathy","enrollment":154},{"nctId":"NCT05478382","phase":"PHASE4","title":"Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects","status":"UNKNOWN","sponsor":"Ajou University School of Medicine","startDate":"2022-10","conditions":"Postoperative Pain, Pregabalin, Spine Surgery","enrollment":132},{"nctId":"NCT05442931","phase":"PHASE1, PHASE2","title":"Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia","status":"UNKNOWN","sponsor":"Minia University","startDate":"2022-05-01","conditions":"Functional Endoscopic Sinus Surgery","enrollment":60},{"nctId":"NCT01366196","phase":"NA","title":"Pregabalin for the Treatment of Pain After Posterior Spinal Fusions","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2008-10","conditions":"Lumbar Spinal Fusions","enrollment":86},{"nctId":"NCT04246619","phase":"PHASE4","title":"Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life","status":"TERMINATED","sponsor":"KRKA","startDate":"2019-11-12","conditions":"Painful Diabetic Peripheral Neuropathy","enrollment":254},{"nctId":"NCT05181852","phase":"PHASE1","title":"Study to Investigate the Pharmacodynamic Effects of IP2015 in Healthy Male Subjects Using the Intradermal Capsaicin Model","status":"UNKNOWN","sponsor":"Initiator Pharma","startDate":"2022-01-05","conditions":"Pain","enrollment":24},{"nctId":"NCT01511640","phase":"EARLY_PHASE1","title":"Behavioral Effects of Pregabalin and Cannabis","status":"COMPLETED","sponsor":"Joshua A. Lile, Ph.D.","startDate":"2017-02-01","conditions":"Cannabis-use Disorders","enrollment":30},{"nctId":"NCT04546334","phase":"NA","title":"Erector Spinae Plane Block in Post-herpetic Neuralgia","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-09-26","conditions":"Postherpetic Neuralgia","enrollment":90},{"nctId":"NCT03472469","phase":"PHASE4","title":"MAST Trial: Multi-modal Analgesic Strategies in Trauma","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Nonspecific Pain Post Traumatic Injury","enrollment":1561},{"nctId":"NCT00676403","phase":"PHASE2","title":"Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-04","conditions":"Restless Legs Syndrome","enrollment":137},{"nctId":"NCT00468845","phase":"PHASE3","title":"Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-06","conditions":"Pain, Postoperative","enrollment":501},{"nctId":"NCT00141219","phase":"PHASE3","title":"Pregabalin Peripheral Neuropathic Pain Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-12","conditions":"Diabetic Neuropathies, Neuralgia","enrollment":241},{"nctId":"NCT01789216","phase":"PHASE3","title":"Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)","status":"COMPLETED","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2013-07","conditions":"Orthopaedic Fractures","enrollment":450},{"nctId":"NCT01455415","phase":"PHASE3","title":"Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-12","conditions":"Painful Diabetic Peripheral Neuropathy","enrollment":306},{"nctId":"NCT00280059","phase":"PHASE3","title":"Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-08","conditions":"Epilepsy, Partial","enrollment":660},{"nctId":"NCT01727791","phase":"PHASE4","title":"A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-12","conditions":"Healthy Lactating Women","enrollment":10},{"nctId":"NCT00551135","phase":"PHASE3","title":"Surgical Pain After Inguinal Hernia Repair (SPAIHR)","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-01","conditions":"Pain, Postoperative, Hernia, Inguinal","enrollment":425},{"nctId":"NCT00645398","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-09","conditions":"Fibromyalgia","enrollment":751},{"nctId":"NCT01432236","phase":"PHASE3","title":"A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-10","conditions":"Fibromyalgia","enrollment":197},{"nctId":"NCT01342198","phase":"PHASE1","title":"An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-06","conditions":"Healthy","enrollment":18},{"nctId":"NCT00610155","phase":"NA","title":"A Methodology Study Of Brain Imaging Of Pain-Killers In Post-Traumatic Neuropathic Pain Patients","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-09","conditions":"Pain","enrollment":18},{"nctId":"NCT00288639","phase":"PHASE4","title":"Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-12","conditions":"Epilepsy","enrollment":98},{"nctId":"NCT01257516","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-02","conditions":"Healthy","enrollment":18},{"nctId":"NCT01202435","phase":"PHASE1","title":"An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2010-10","conditions":"Healthy","enrollment":18},{"nctId":"NCT01443169","phase":"PHASE1","title":"A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-03","conditions":"Healthy","enrollment":16},{"nctId":"NCT01389596","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-09-27","conditions":"Epilepsy, Partial Seizures","enrollment":295},{"nctId":"NCT02072824","phase":"PHASE3","title":"A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2014-09-16","conditions":"Partial Onset Seizures","enrollment":175},{"nctId":"NCT01747915","phase":"PHASE3","title":"A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-04-03","conditions":"Generalized Tonic Clonic Seizures","enrollment":219},{"nctId":"NCT04647773","phase":"PHASE2, PHASE3","title":"To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain","status":"UNKNOWN","sponsor":"Haisco Pharmaceutical Group Co., Ltd.","startDate":"2020-12-02","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":687},{"nctId":"NCT04600037","phase":"NA","title":"Pregabalin Treatment for Trigger Points","status":"COMPLETED","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2014-04-26","conditions":"Myofascial Pain Syndrome","enrollment":40},{"nctId":"NCT02482818","phase":"PHASE1, PHASE2","title":"Efficacy of Pregabalin on Chronic Cough","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2015-09","conditions":"Cough","enrollment":40},{"nctId":"NCT03942796","phase":"NA","title":"Pregabalin Versus Pulsed Radiofrequency Ablation for Treatment of Chronic Post-thoracotomy Pain","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2018-01-01","conditions":"Chronic Post-thoracotomy Pain","enrollment":30},{"nctId":"NCT04499209","phase":"PHASE1","title":"Pharmacokinetics Study of XG005 Capsule","status":"COMPLETED","sponsor":"Xgene Pharmaceutical Group","startDate":"2017-10-16","conditions":"Pain","enrollment":50},{"nctId":"NCT04265456","phase":"PHASE1","title":"A Phase 1 Study to Evaluate Pregabalin and Acetaminophen in Healthy Volunteers","status":"COMPLETED","sponsor":"Nevakar, Inc.","startDate":"2020-01-14","conditions":"Postoperative Pain","enrollment":63},{"nctId":"NCT03179345","phase":"PHASE4","title":"Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica","status":"COMPLETED","sponsor":"Depomed","startDate":"2015-09-24","conditions":"Healthy","enrollment":32},{"nctId":"NCT04342065","phase":"PHASE2, PHASE3","title":"Pregabalin Versus Celecoxib on Sevoflurane and Analgesic Consumption in Spine Fixation Surgery","status":"COMPLETED","sponsor":"South Egypt Cancer Institute","startDate":"2019-01-01","conditions":"Post-Operative Pain","enrollment":200},{"nctId":"NCT01504412","phase":"PHASE2","title":"Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Daiichi Sankyo Co., Ltd.","startDate":"2012-01","conditions":"Pain, Diabetic Peripheral Neuropathy","enrollment":450},{"nctId":"NCT02037165","phase":"PHASE1","title":"Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2014-01-21","conditions":"Healthy","enrollment":25},{"nctId":"NCT00994786","phase":"PHASE4","title":"A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder","status":"COMPLETED","sponsor":"McMaster University","startDate":"2009-01","conditions":"Obsessive-Compulsive Disorder","enrollment":15},{"nctId":"NCT01117766","phase":"NA","title":"Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2006-12","conditions":"Neuropathic Pain","enrollment":31},{"nctId":"NCT02985216","phase":"PHASE3","title":"Clinical Trial of YHD1119 in Patients With Peripheral Neuropathic Pain","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-02-07","conditions":"Peripheral Neuropathic Pain","enrollment":371},{"nctId":"NCT03191136","phase":"PHASE1","title":"Clinical Trial to Assess the Effect of Food on the Pharmacokinetics of YHD1119 in Healthy Volunteers","status":"COMPLETED","sponsor":"Yuhan Corporation","startDate":"2017-05-10","conditions":"Peripheral Neuropathic Pain","enrollment":24},{"nctId":"NCT03407430","phase":"PHASE2","title":"Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain","status":"TERMINATED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2016-01-27","conditions":"Breast Cancer, Lymphoma, Pain","enrollment":11},{"nctId":"NCT01768988","phase":"PHASE4","title":"Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study","status":"TERMINATED","sponsor":"Parc de Salut Mar","startDate":"2012-08","conditions":"Pancreatic Cancer, Visceral Pain","enrollment":20},{"nctId":"NCT02727101","phase":"PHASE4","title":"Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.","status":"TERMINATED","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2015-11","conditions":"Epilepsy","enrollment":8},{"nctId":"NCT00787462","phase":"NA","title":"Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2008-02","conditions":"Small-Fiber Neuropathy","enrollment":3},{"nctId":"NCT02952937","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Pregabalin CR(Controlled-release) Table 300 mg","status":"COMPLETED","sponsor":"GL Pharm Tech Corporation","startDate":"2016-11","conditions":"Healthy","enrollment":24},{"nctId":"NCT02955472","phase":"PHASE1","title":"Bioequivalence Study of Two Formulations of Pregabalin CR (Controlled-release) Table 150 mg","status":"COMPLETED","sponsor":"GL Pharm Tech Corporation","startDate":"2016-11","conditions":"Healthy","enrollment":24},{"nctId":"NCT02276989","phase":"PHASE2","title":"Evaluation of a Compliance Marker in Prescription Opioid Abusers With Chronic Pain","status":"WITHDRAWN","sponsor":"Georgetown University","startDate":"2014-12","conditions":"Compliance, Chronic Pain","enrollment":""},{"nctId":"NCT01821430","phase":"PHASE2","title":"Increased Sensitivity to Pain Caused by Opioids in People Who Have Abused Prescription Opioids","status":"TERMINATED","sponsor":"Georgetown University","startDate":"2013-03","conditions":"Chronic Pain","enrollment":4},{"nctId":"NCT00977197","phase":"PHASE2","title":"A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2010-03","conditions":"Irritable Bowel Syndrome","enrollment":85},{"nctId":"NCT02868814","phase":"PHASE3","title":"The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2016-05","conditions":"Fibromyalgia","enrollment":240},{"nctId":"NCT02868801","phase":"PHASE3","title":"Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2015-03","conditions":"Postherpetic Neuralgia","enrollment":280},{"nctId":"NCT02826317","phase":"","title":"Neuropathic Evaluation of Postoperative Pain","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2015-01","conditions":"Neuropathic Pain Evaluation","enrollment":800},{"nctId":"NCT01333956","phase":"PHASE1, PHASE2","title":"Effects of Pregabalin on Pain After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2011-05","conditions":"Primary Total Knee Arthroplasty","enrollment":120},{"nctId":"NCT02724293","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Peri-operative Pregabalin After Radical Cystectomy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2014-09","conditions":"Postoperative Pain Following Radical Cystectomy","enrollment":60},{"nctId":"NCT01058642","phase":"PHASE2","title":"Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia","status":"TERMINATED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2010-01","conditions":"Postherpetic Neuralgia","enrollment":41},{"nctId":"NCT00837941","phase":"PHASE2","title":"A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)","status":"WITHDRAWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-04","conditions":"Painful Diabetic Neuropathy","enrollment":""},{"nctId":"NCT00852436","phase":"PHASE2","title":"Pregabalin and Orofacial Neuropathic Pain","status":"TERMINATED","sponsor":"University of Toronto","startDate":"2009-02","conditions":"Neuropathic Pain, Orofacial Pain","enrollment":1},{"nctId":"NCT02455726","phase":"NA","title":"Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease","status":"UNKNOWN","sponsor":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","startDate":"2015-09","conditions":"Peripheral Arterial Disease","enrollment":150},{"nctId":"NCT00891397","phase":"NA","title":"Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)","status":"TERMINATED","sponsor":"McMaster University","startDate":"2007-11","conditions":"Complex Regional Pain Syndromes","enrollment":14},{"nctId":"NCT02327000","phase":"PHASE1","title":"A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers","status":"COMPLETED","sponsor":"GL Pharm Tech Corporation","startDate":"2014-10","conditions":"Healthy","enrollment":40},{"nctId":"NCT00908375","phase":"PHASE4","title":"Efficacy of Pregabalin in Patients With Radicular Pain","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2009-05","conditions":"Neuropathy; Radicular, Lumbar, Lumbosacral, Failed Back Surgery Syndrome, Spinal Stenosis","enrollment":39},{"nctId":"NCT01603394","phase":"PHASE4","title":"Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia","status":"TERMINATED","sponsor":"Pfizer","startDate":"2012-10","conditions":"Postherpetic Neuralgia","enrollment":9},{"nctId":"NCT01397006","phase":"PHASE4","title":"Fibromyalgia of Less Than One Year Duration. Study of Pregabalin","status":"WITHDRAWN","sponsor":"Newton-Wellesley Hospital","startDate":"2011-09","conditions":"Fibromyalgia","enrollment":""},{"nctId":"NCT01591980","phase":"PHASE4","title":"Effects of Perioperative Pregabalin for Post-Craniotomy Pain","status":"WITHDRAWN","sponsor":"Unity Health Toronto","startDate":"2013-08","conditions":"Chronic Postoperative Pain, Headache","enrollment":""},{"nctId":"NCT01364298","phase":"PHASE4","title":"Efficacy and Safety of Gabapentin/B-complex Versus Pregabalin in Diabetic Peripheral Neuropathy Pain Management","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2011-04","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":353}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lyrica Dose Level 2"],"phase":"phase_3","status":"active","brandName":"Pregabalin Dose Level 2","genericName":"Pregabalin Dose Level 2","companyName":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","companyId":"pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters. Used for Neuropathic pain (diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury), Partial-onset seizures (adjunctive therapy), Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":2},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}